Pharmaxis Announces New Board Appointment
Release Date: 25/07/2012 12:00am
Pharmaceutical company Pharmaxis (ASX: PXS) today announced the appointment of experienced international pharmaceutical executive Dr Simon Buckingham, to its Board of Directors. Dr Buckingham has more than 20 years experience in top tier pharmaceutical and biotechnology companies with expertise in general management, sales and marketing, clinical development, business development and corporate strategic planning.
Categories: News and Media